AORT
Price
$30.49
Change
-$0.36 (-1.17%)
Updated
Jul 18 closing price
Capitalization
873.56M
10 days until earnings call
TCMD
Price
$9.52
Change
-$0.49 (-4.90%)
Updated
Jul 18 closing price
Capitalization
369.35M
21 days until earnings call
Interact to see
Advertisement

AORT vs TCMD

Header iconAORT vs TCMD Comparison
Open Charts AORT vs TCMDBanner chart's image
Artivion
Price$30.49
Change-$0.36 (-1.17%)
Volume$282.01K
Capitalization873.56M
Tactile Systems Technology
Price$9.52
Change-$0.49 (-4.90%)
Volume$146.97K
Capitalization369.35M
AORT vs TCMD Comparison Chart in %
Loading...
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AORT vs. TCMD commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AORT is a Hold and TCMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (AORT: $30.49 vs. TCMD: $9.52)
Brand notoriety: AORT and TCMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AORT: 81% vs. TCMD: 54%
Market capitalization -- AORT: $873.56M vs. TCMD: $369.35M
AORT [@Medical Specialties] is valued at $873.56M. TCMD’s [@Medical Specialties] market capitalization is $369.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AORT’s FA Score shows that 0 FA rating(s) are green whileTCMD’s FA Score has 1 green FA rating(s).

  • AORT’s FA Score: 0 green, 5 red.
  • TCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, both AORT and TCMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AORT’s TA Score shows that 2 TA indicator(s) are bullish while TCMD’s TA Score has 3 bullish TA indicator(s).

  • AORT’s TA Score: 2 bullish, 6 bearish.
  • TCMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than AORT.

Price Growth

AORT (@Medical Specialties) experienced а -3.08% price change this week, while TCMD (@Medical Specialties) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

AORT is expected to report earnings on Jul 31, 2025.

TCMD is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AORT($874M) has a higher market cap than TCMD($369M). AORT has higher P/E ratio than TCMD: AORT (434.78) vs TCMD (12.72). AORT YTD gains are higher at: 6.646 vs. TCMD (-44.425). AORT has higher annual earnings (EBITDA): 26.8M vs. TCMD (24.5M). TCMD has more cash in the bank: 75.2M vs. AORT (58.9M). TCMD has less debt than AORT: TCMD (50.4M) vs AORT (358M). AORT has higher revenues than TCMD: AORT (354M) vs TCMD (274M).
AORTTCMDAORT / TCMD
Capitalization874M369M237%
EBITDA26.8M24.5M109%
Gain YTD6.646-44.425-15%
P/E Ratio434.7812.723,417%
Revenue354M274M129%
Total Cash58.9M75.2M78%
Total Debt358M50.4M710%
FUNDAMENTALS RATINGS
AORT vs TCMD: Fundamental Ratings
AORT
TCMD
OUTLOOK RATING
1..100
8726
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
9276
PRICE GROWTH RATING
1..100
4789
P/E GROWTH RATING
1..100
7717
SEASONALITY SCORE
1..100
3150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCMD's Valuation (62) in the Medical Specialties industry is in the same range as AORT (94). This means that TCMD’s stock grew similarly to AORT’s over the last 12 months.

AORT's Profit vs Risk Rating (61) in the Medical Specialties industry is somewhat better than the same rating for TCMD (100). This means that AORT’s stock grew somewhat faster than TCMD’s over the last 12 months.

TCMD's SMR Rating (76) in the Medical Specialties industry is in the same range as AORT (92). This means that TCMD’s stock grew similarly to AORT’s over the last 12 months.

AORT's Price Growth Rating (47) in the Medical Specialties industry is somewhat better than the same rating for TCMD (89). This means that AORT’s stock grew somewhat faster than TCMD’s over the last 12 months.

TCMD's P/E Growth Rating (17) in the Medical Specialties industry is somewhat better than the same rating for AORT (77). This means that TCMD’s stock grew somewhat faster than AORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AORTTCMD
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 25 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AORT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMCQX13.27N/A
N/A
GMO US Equity VI
BMSFX14.88N/A
N/A
MFS Blended Research Mid Cap Eq A
AMVYX16.13N/A
N/A
American Century Mid Cap Value Y
VSQAX17.74-0.02
-0.11%
Invesco MSCI World SRI Index A
VLCGX17.47-0.05
-0.29%
VALIC Company I Large Capital Growth

AORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AORT has been loosely correlated with ITGR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AORT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AORT
1D Price
Change %
AORT100%
-1.17%
ITGR - AORT
47%
Loosely correlated
-1.88%
SIBN - AORT
47%
Loosely correlated
-0.66%
BSX - AORT
46%
Loosely correlated
-0.95%
TCMD - AORT
44%
Loosely correlated
-4.90%
LMAT - AORT
41%
Loosely correlated
-2.84%
More

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with OFIX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
-4.90%
OFIX - TCMD
54%
Loosely correlated
-2.03%
AORT - TCMD
43%
Loosely correlated
-1.17%
BVS - TCMD
42%
Loosely correlated
-3.54%
BLFS - TCMD
39%
Loosely correlated
-1.00%
CSTL - TCMD
39%
Loosely correlated
-4.89%
More